Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ma

Showing results (181-190 of 357) with videos related to

Pageof 36
Sort By:
Gastro Hep Advances|June 8, 2026
Efficacy of Upadacitinib Retreatment or Dose Escalation After Loss of Response in Ulcerative Colitis: Data From the Open-Label Extension of the U-ACTIVATE StudyRemo Panaccione, Jean-Frédéric Colombel, Marla Dubinsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 21, 2020
Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACTJurij Hanzel, Christopher Ma, Guangyong Zou, et al.
Journal of Crohn'S & Colitis|November 7, 2023
Pharmacological Therapies for the Management of Fistulizing Crohn's Disease: A Systematic Review and Meta-AnalysisSudheer K Vuyyuru, Virginia Solitano, Neeraj Narula, et al.
Frontiers in Neuroanatomy|August 28, 2020
Characterization of Vimentin-Immunoreactive Astrocytes in the Human BrainLiam Anuj O'Leary, Maria Antonietta Davoli, Claudia Belliveau, et al.
BMJ Open|June 12, 2017
Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyChristopher Ma, Remo Panaccione, Richard N Fedorak, et al.
Inflammatory Bowel Diseases|January 29, 2016
Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort StudyChristopher Ma, Candace L Beilman, Vivian W Huang, et al.
Journal of Clinical Medicine|October 16, 2025
Navigating Care Amid Crisis: The Impact of the COVID-19 Pandemic on Eosinophilic Esophagitis Management in CanadaSunil Samnani, Muhammad Anas Fazal, Krystyna Pokraka, et al.
Eclinicalmedicine|December 11, 2024
Corrigendum to "Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials" volume 72, 102621Sudheer K Vuyyuru, Christopher Ma, Tran M Nguyen, et al.
Crohn'S & Colitis 360|May 25, 2026
The UCEIS and UC-100 score were responsive endoscopic and global indices in a phase 2 trial of ulcerative colitisSudheer K Vuyyuru, Simon Travis, Soushyant Kiarasi, et al.
Endoscopy International Open|June 21, 2024
Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic reviewAnna Lerman Silverman, Hicham Bouchiba, Arthur Aelvoet, et al.
Pageof 36

Showing results (181-190 of 357) with videos related to

Sort By:
Pageof 36
Gastro Hep Advances|June 8, 2026
Efficacy of Upadacitinib Retreatment or Dose Escalation After Loss of Response in Ulcerative Colitis: Data From the Open-Label Extension of the U-ACTIVATE StudyRemo Panaccione, Jean-Frédéric Colombel, Marla Dubinsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 21, 2020
Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACTJurij Hanzel, Christopher Ma, Guangyong Zou, et al.
Journal of Crohn'S & Colitis|November 7, 2023
Pharmacological Therapies for the Management of Fistulizing Crohn's Disease: A Systematic Review and Meta-AnalysisSudheer K Vuyyuru, Virginia Solitano, Neeraj Narula, et al.
Frontiers in Neuroanatomy|August 28, 2020
Characterization of Vimentin-Immunoreactive Astrocytes in the Human BrainLiam Anuj O'Leary, Maria Antonietta Davoli, Claudia Belliveau, et al.
BMJ Open|June 12, 2017
Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyChristopher Ma, Remo Panaccione, Richard N Fedorak, et al.
Inflammatory Bowel Diseases|January 29, 2016
Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort StudyChristopher Ma, Candace L Beilman, Vivian W Huang, et al.
Journal of Clinical Medicine|October 16, 2025
Navigating Care Amid Crisis: The Impact of the COVID-19 Pandemic on Eosinophilic Esophagitis Management in CanadaSunil Samnani, Muhammad Anas Fazal, Krystyna Pokraka, et al.
Eclinicalmedicine|December 11, 2024
Corrigendum to "Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials" volume 72, 102621Sudheer K Vuyyuru, Christopher Ma, Tran M Nguyen, et al.
Crohn'S & Colitis 360|May 25, 2026
The UCEIS and UC-100 score were responsive endoscopic and global indices in a phase 2 trial of ulcerative colitisSudheer K Vuyyuru, Simon Travis, Soushyant Kiarasi, et al.
Endoscopy International Open|June 21, 2024
Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic reviewAnna Lerman Silverman, Hicham Bouchiba, Arthur Aelvoet, et al.
Pageof 36